Clover Health stockholders elect directors, approve pay, ratify auditor at 2025 annual meeting

CLOVER HEALTH INVESTMENTS, CORP. /DE

Dr. Anna U. Loengard and William G. Robinson, Jr. elected as Class I directors for term expiring 2028.
Non-binding say-on-pay proposal for 2024 executive compensation approved with over 988 million votes in favor.
Ratification of Ernst & Young LLP as independent auditor for FY2025 received over 1.15 billion votes in favor.
All proposals passed with substantial majority; broker non-votes on first two items totaled ~162 million.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.